recurrent childhood pineoblastoma
Showing 1 - 25 of >10,000
CNS Tumor, Diffuse Intrinsic Pontine Glioma, Diffuse Midline Glioma Trial in Seattle (SCRI-CARB7H3(s); B7H3-specific chimeric
Recruiting
- Central Nervous System Tumor
- +10 more
- SCRI-CARB7H3(s); B7H3-specific chimeric antigen receptor (CAR) T cel
-
Seattle, WashingtonSeattle Children's Hospital
Dec 14, 2022
Childhood Choroid Plexus Tumor, Childhood Ependymoblastoma, Childhood Grade III Meningioma Trial in United States (palbociclib
Terminated
- Childhood Choroid Plexus Tumor
- +18 more
- palbociclib isethionate
- +2 more
-
Los Angeles, California
- +10 more
Feb 10, 2021
CNS Embryonal Tumor With Rhabdoid Features, CNS Embryonal Tumor, Not Otherwise Specified, CNS Ganglioneuroblastoma Trial in
Active, not recruiting
- Central Nervous System Embryonal Tumor With Rhabdoid Features
- +14 more
- Adavosertib
- Irinotecan Hydrochloride
-
Birmingham, Alabama
- +23 more
Oct 7, 2022
Childhood Choroid Plexus Tumor, Childhood Medulloblastoma, Childhood Pineoblastoma Trial in Detroit (filgrastim)
Terminated
- Childhood Choroid Plexus Tumor
- +10 more
- filgrastim
-
Detroit, MichiganBarbara Ann Karmanos Cancer Institute
Oct 2, 2020
Ex Vivo Drug Sensitivity Testing and Multi-Omics Profiling
Recruiting
- Recurrent Childhood Acute Myeloid Leukemia
- +17 more
-
Miami, FloridaNicklaus Children's Hospital
May 13, 2023
Ex Vivo Drug Sensitivity Testing and Mutation Profiling
Completed
- Recurrent Childhood Acute Myeloid Leukemia
- +13 more
-
Miami, FloridaNicklaus Children's Hospital
Jan 18, 2023
FFPE Samples From Younger Patients With Rhabdomyosarcoma
Completed
- Alveolar Childhood Rhabdomyosarcoma
- +2 more
-
Jinan, Shandong, ChinaJinan central hospital affiliated to Shandong First Medical Univ
Sep 10, 2023
CNS Tumor, Pediatric, Glioma, Ependymoma Trial in Seattle (EGFR806-specific chimeric antigen receptor (CAR) T cell)
Active, not recruiting
- Central Nervous System Tumor, Pediatric
- +8 more
- EGFR806-specific chimeric antigen receptor (CAR) T cell
-
Seattle, WashingtonSeattle Children's Hospital
Jan 18, 2023
CNS Tumor, Pediatric, Glioma, Ependymoma Trial in Seattle (HER2-specific chimeric antigen receptor (CAR) T cell)
Recruiting
- Central Nervous System Tumor, Pediatric
- +8 more
- HER2-specific chimeric antigen receptor (CAR) T cell
-
Seattle, WashingtonSeattle Children's Hospital
Dec 14, 2022
Childhood Asthma With Acute Exacerbation Trial in Gentofte, Naestved (Azithromycin, Placebo mixture)
Active, not recruiting
- Childhood Asthma With Acute Exacerbation
- Azithromycin
- Placebo mixture
-
Gentofte, Copenhagen, Denmark
- +1 more
Nov 21, 2022
Childhood Astrocytoma, Childhood Atypical Teratoid/Rhabdoid Tumor, Diffuse Intrinsic Pontine Glioma Trial in Rochester
Active, not recruiting
- Childhood Astrocytoma
- +9 more
- Laboratory Biomarker Analysis
- +2 more
-
Rochester, MinnesotaMayo Clinic
Sep 8, 2022
Diffuse Intrinsic Pontine Glioma, Diffuse Midline Glioma, Recurrent CNS Tumor, Adult Trial in Seattle (SC-CAR4BRAIN)
Not yet recruiting
- Diffuse Intrinsic Pontine Glioma
- +4 more
- SC-CAR4BRAIN
-
Seattle, WashingtonSeattle Children's Hospital
Mar 3, 2023
Juvenile Myelomonocytic Leukemia, Recurrent Acute Biphenotypic Leukemia, Recurrent Acute Undifferentiated Leukemia Trial in
Suspended
- Juvenile Myelomonocytic Leukemia
- +27 more
- CD8+ and CD4+ Donor Memory T-cells-expressing HA1-Specific TCR
- +2 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Jan 11, 2023
DNA Samples From Acute Lymphoblastic Leukemia or Acute Myeloid
Completed
- Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11
- +8 more
- Laboratory Biomarker Analysis
-
Philadelphia, PennsylvaniaChildrens Oncology Group
Jul 12, 2022
Recurrent Medulloblastoma, Recurrent Brain Tumor, Childhood, Malignant Glioma Trial in Durham (PEP-CMV)
Recruiting
- Recurrent Medulloblastoma
- +2 more
-
Durham, North CarolinaDuke University Medical Center
Jan 8, 2022
Brain Tumor, Recurrent, Brain Tumor, Pediatric, CNS Tumors Trial in Houston (RRx-001, Temozolomide, Irinotecan)
Recruiting
- Brain Tumor, Recurrent
- +3 more
- RRx-001
- +2 more
-
Houston, TexasTexas Children's Cancer Center
Aug 15, 2022
Brain Tumor, Medulloblastoma, Brain Metastases Trial in Atlanta (WP1066)
Recruiting
- Brain Tumor
- +2 more
-
Atlanta, GeorgiaChildren's Healthcare of Atlanta (CHOA)
Jul 24, 2022
Tumor Tissue Samples From Young Acute Lymphoblastic Leukemia
Completed
- Childhood Acute Lymphoblastic Leukemia in Remission
- Recurrent Childhood Acute Lymphoblastic Leukemia
- Laboratory Biomarker Analysis
-
Philadelphia, PennsylvaniaChildrens Oncology Group
Aug 12, 2022
Childhood CNS Tumor Trial in Washington (genetic, radiation, drug)
Not yet recruiting
- Childhood CNS Tumor
- SGT-53
- +4 more
-
Washington, District of ColumbiaChildren's National Medical Center
Feb 7, 2022
Neurofibromatosis Type 1, Recurrent Childhood Brain Stem Glioma, Recurrent Childhood Visual Pathway Glioma Trial in United
Completed
- Neurofibromatosis Type 1
- +4 more
- Laboratory Biomarker Analysis
- +2 more
-
Los Angeles, California
- +11 more
Apr 22, 2022
Medulloblastoma, Childhood Trial in Worldwide (177Lu-DTPA-omburtamab)
Terminated
- Medulloblastoma, Childhood
-
Rochester, Minnesota
- +9 more
Aug 15, 2022
Brain and CNS Tumors, Intraocular Melanoma, Lung Cancer Trial in New York (genetic, other, radiation)
Active, not recruiting
- Brain and Central Nervous System Tumors
- +9 more
- DNA analysis
- +4 more
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Oct 28, 2021
Recurrent B-Cell Childhood Acute Lymphoblastic Leukemia, Recurrent Childhood B-Lymphoblastic Lymphoma Trial in San Diego,
Completed
- Recurrent B-Cell Childhood Acute Lymphoblastic Leukemia
- Recurrent Childhood B-Lymphoblastic Lymphoma
- dexamethasone
- +18 more
-
San Diego, California
- +2 more
Sep 13, 2022
Childhood Brain Tumor, Recurrent Childhood Brain Tumor Trial in Portland (Dynamic Contrast-Enhanced Magnetic Resonance Imaging,
Completed
- Childhood Brain Neoplasm
- Recurrent Childhood Brain Neoplasm
- Dynamic Contrast-Enhanced Magnetic Resonance Imaging
- +3 more
-
Portland, OregonOHSU Knight Cancer Institute
Jul 11, 2022